6-Azaniumylcyclohex-3-ene-1-carboxylate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 6-Azaniumylcyclohex-3-ene-1-carboxylate
• 化学式: C₇H₁₁NO₂
• mdl: MFCD00278407
• 分子量: 141.17
• InChiKey: CQINMZNDBYQHKR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.7
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-Azaniumylcyclohex-3-ene-1-carboxylate 、 6-甲氧基-2,3,4,5-四氢吡啶 生成 1,4,4a,6,7,8,9,11a-Octahydropyrido[2,1-b]quinazolin-11-one
  参考文献：
  名称：

  FUELOEP, F.;HUBER, I.;BERNATH, G.;TOTH, G.;SIMON, K.;HERMECZ, I.;MESZAROS+, HETEROCYCLES, 1984, 21, N 2, 678

  摘要：

  DOI：

文献信息

• Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
  申请人：Levin I. Jeremy

  公开号：US20060211730A1

  公开（公告）日：2006-09-21

  This invention provides compounds of Formula I, having the structure: that are useful in treating diseases or disorders mediated by TNF-α, such as arthritis (rheumatoid arthritis (RA), juvenile RA, psoriatic arthritis, osteoarthritis etc), tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and HIV infection, ankylosing spondylitis, psoriasis, sepsis, multiple sclerosis, Crohn's disease, degenerative cartilage loss, asthma, idiopathic pulmonary fibrosis, vasculitis, systemic lupus erythematosus, irritable bowel syndrome, acute coronary syndrome, hepatitis C, cachexia, COPD, stroke or type 2 diabetes, and for alleviation of symptoms thereof. The invention further provides methods for use of the compounds.

  这项发明提供了具有结构的Formula I的化合物，这些化合物在治疗由TNF-α介导的疾病或紊乱方面非常有用，如关节炎（类风湿关节炎（RA），幼年RA，银屑病性关节炎，骨关节炎等），肿瘤转移，组织溃疡，异常伤口愈合，牙周病，骨病，糖尿病（胰岛素抵抗）和HIV感染，强直性脊柱炎，银屑病，败血症，多发性硬化，克罗恩病，退行性软骨丢失，哮喘，特发性肺纤维化，血管炎，系统性红斑狼疮，肠易激综合征，急性冠状动脉综合征，丙型肝炎，虚弱，慢性阻塞性肺病，中风或2型糖尿病的缓解症状。该发明还提供了使用这些化合物的方法。
• Diaminopropionic acid derivatives
  申请人：Fotouhi Nader

  公开号：US20050080119A1

  公开（公告）日：2005-04-14

  A compound of formula 1a which is useful for treating reperfusion injury, and salts, prodrugs, and related compounds.

  一种用于治疗再灌注损伤的化合物，其化学式为1a，以及其盐、前药和相关化合物。
• Templated molecules and methods for using such molecules
  申请人：Nuevolution A/S

  公开号：US20040049008A1

  公开（公告）日：2004-03-11

  The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of libraries which can be screened for e.g. therapeutic activity.

  本发明涉及一种合成模板分子的方法。在本发明的一个方面中，模板分子与模板连接，从而进行模板合成。该方法可生成图书馆，可对其进行筛选，例如用于治疗活性。
• TEMPLATED MOLECULES AND METHODS FOR USING SUCH MOLECULES
  申请人：Pedersen Henrik

  公开号：US20100016177A1

  公开（公告）日：2010-01-21

  The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of libraries which can be screened for e.g. therapeutic activity.

  本发明涉及一种合成模板分子的方法。在本发明的一个方面中，模板分子与模板相连，该模板模板化了合成它们的过程。该方法允许生成可筛选例如治疗活性的库。
• Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors
  申请人：Molteni Valentina

  公开号：US20070149538A1

  公开（公告）日：2007-06-28

  Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

  本文描述了包含二芳胺结构特征的化合物。还描述了制备这种化合物的方法，使用这种化合物调节c-kit受体活性的方法，以及包含这种化合物的药物组合物和药物。本文还描述了使用这种化合物、药物组合物和药物治疗和/或预防和/或抑制和/或改善与c-kit受体活性相关的病理学和/或症状学疾病或状况的方法。